Recent insider trading activity from Holloway Michael Andrew, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 15, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Holloway Michael Andrew | Director | A | Options to Purchase Common Stock | 25000 | $0.00 | 25,000.0000 | 2,249,290 | 9999.99% | 1.11% |